Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International

Wikipedia Affiliate Button

Home > Press > Magnetic nanoparticles can 'burn' cancer cells: Magnetic hyperthermia is still a highly experimental cancer treatment, but new research shows that the therapy is tunable

Abstract:
Unfortunately, cancer isn't simply a single disease, and some types, like pancreas, brain or liver tumours, are still difficult to treat with chemotherapy, radiation therapy or surgery, leading to low survival rates for patients. Thankfully, new therapies are emerging, like therapeutic hyperthermia, which heats tumours by firing nanoparticles into tumour cells. In a new study published in EPJ B, Angl Apostolova from the University of Architecture, Civil Engineering and Geodesy in Sofia, Bulgaria and colleagues show that tumour cells' specific absorption rate of destructive heat depends on the diameter of the nanoparticles and the composition of the magnetic material used to deliver the heat to the tumour.

Magnetic nanoparticles can 'burn' cancer cells: Magnetic hyperthermia is still a highly experimental cancer treatment, but new research shows that the therapy is tunable

Heidelberg, Germany | Posted on April 7th, 2019

Magnetic nanoparticles delivered close to the tumour cells are activated using alternating magnetic fields. Hyperthermia therapy is effective if the nanoparticles are absorbed well by the tumour cells but not by cells in healthy tissue. Therefore, its effectiveness depends on the specific absorption rate. Bulgarian scientists have studied several nanoparticles made of an iron oxide material called ferrite, to which are added small quantities of copper, nickel, manganese or cobalt atoms--a method called dopping.

The researchers investigated magnetic hyperthermia based on these particles, both in mice and in cell cultures, for two distinct heating methods. The methods differ in terms of how the heat is generated in the particles: via direct or indirect coupling between the magnetic field and the magnetic moment of the particles.

The authors show that the tumour absorption rate greatly depends on the diameter of the nanoparticles. Surprisingly, the absorption rate increases as particle diameter increases, as long as the level of doping of the material is sufficiently high and the diameter doesn't exceed a set maximum value (max. 14 nanometres for cobalt doping, 16 nm for copper).

####

For more information, please click here

Contacts:
Sabine Lehr

49-622-144-878-336

Copyright © Springer

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related Links

References

Related News Press

News and information

A light-activated remote control for cells April 17th, 2019

NEXUS 2019: Global Summit on Energy Materials and Green Nanotechnology April 16th, 2019

Arrowhead Pharmaceuticals Receives FDA Clearance to Begin Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease April 15th, 2019

New microscopy method provides more details about nanocomposites April 12th, 2019

Cancer

'Nanobodies' from alpacas could help bring CAR T-cell therapy to solid tumors: Unusually small antibodies, targeted to the tumor micro-environment, curb melanoma and colon cancer in mouse models April 11th, 2019

Nanobiotix Receives European Market APPROVAL for Cancer Therapy Hensify (NBTXR3) April 3rd, 2019

Combination of first-in-class NBTXR3, radiotherapy, and anti-PD-1 immunotherapy demonstrate efficacy in treating resistant pre-clinical in vivo models of lung cancer April 3rd, 2019

Low-dose radiation therapy improves delivery of therapeutic nanoparticles to brain tumors March 29th, 2019

Possible Futures

A light-activated remote control for cells April 17th, 2019

Oregon scientists drill into white graphene to create artificial atoms: Patterned on a microchip and working in ambient conditions, the atoms could lead to rapid advancements in new quantum-based technology April 12th, 2019

2D gold quantum dots are atomically tunable with nanotubes April 11th, 2019

'Nanobodies' from alpacas could help bring CAR T-cell therapy to solid tumors: Unusually small antibodies, targeted to the tumor micro-environment, curb melanoma and colon cancer in mouse models April 11th, 2019

Nanomedicine

A light-activated remote control for cells April 17th, 2019

Arrowhead Pharmaceuticals Receives FDA Clearance to Begin Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease April 15th, 2019

Arrowhead Presents Clinical Data on JNJ-3989 (ARO-HBV) at The International Liver Congress™ April 12th, 2019

'Nanobodies' from alpacas could help bring CAR T-cell therapy to solid tumors: Unusually small antibodies, targeted to the tumor micro-environment, curb melanoma and colon cancer in mouse models April 11th, 2019

Discoveries

A light-activated remote control for cells April 17th, 2019

Arrowhead Pharmaceuticals Receives FDA Clearance to Begin Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease April 15th, 2019

New microscopy method provides more details about nanocomposites April 12th, 2019

Oregon scientists drill into white graphene to create artificial atoms: Patterned on a microchip and working in ambient conditions, the atoms could lead to rapid advancements in new quantum-based technology April 12th, 2019

Announcements

A light-activated remote control for cells April 17th, 2019

NEXUS 2019: Global Summit on Energy Materials and Green Nanotechnology April 16th, 2019

Arrowhead Pharmaceuticals Receives FDA Clearance to Begin Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease April 15th, 2019

New microscopy method provides more details about nanocomposites April 12th, 2019

Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers

A light-activated remote control for cells April 17th, 2019

Oregon scientists drill into white graphene to create artificial atoms: Patterned on a microchip and working in ambient conditions, the atoms could lead to rapid advancements in new quantum-based technology April 12th, 2019

2D gold quantum dots are atomically tunable with nanotubes April 11th, 2019

'Nanobodies' from alpacas could help bring CAR T-cell therapy to solid tumors: Unusually small antibodies, targeted to the tumor micro-environment, curb melanoma and colon cancer in mouse models April 11th, 2019

Nanobiotechnology

A light-activated remote control for cells April 17th, 2019

Arrowhead Pharmaceuticals Receives FDA Clearance to Begin Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease April 15th, 2019

Arrowhead Presents Clinical Data on JNJ-3989 (ARO-HBV) at The International Liver Congress™ April 12th, 2019

'Nanobodies' from alpacas could help bring CAR T-cell therapy to solid tumors: Unusually small antibodies, targeted to the tumor micro-environment, curb melanoma and colon cancer in mouse models April 11th, 2019

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project